The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Combining two strategies to improve perfusion and drug delivery in solid tumors
Open accessAbstract
Blood perfusion in tumors can be significantly lower than that in the surrounding normal tissue owing to the leakiness and/or compression of tumor blood vessels. Impaired perfusion reduces oxygen supply and results in a hypoxic microenvironment. Hypoxia promotes tumor progression and immunosuppression, and enhances the invasive and metastatic potential of cancer cells. Furthermore, poor perfusion lowers the delivery of systemically administered drugs. Therapeutic strategies to improve perfusion include reduction in vascular permeability by vascular normalization and vascular decompression by alleviating physical forces (solid stress) inside tumors. Both strategies have shown promise, but guidelines on how to use these strategies optimally are lacking. To this end, we developed a mathematical model to guide the optimal use of these strategies. The model accounts for vascular, transvascular, and interstitial fluid and drug transport as well as the diameter and permeability of tumor vessels. Model simulations reveal an optimal perfusion region when vessels are uncompressed, but not very leaky. Within this region, intratumoral distribution of drugs is optimized, particularly for drugs 10 nm in diameter or smaller and of low binding affinity. Therefore, treatments should modify vessel diameter and/or permeability such that perfusion is optimal. Vascular normalization is more effective for hyperpermeable but largely uncompressed vessels (e.g., glioblastomas), whereas solid stress alleviation is more beneficial for compressed but less-permeable vessels (e.g., pancreatic ductal adenocarcinomas). In the case of tumors with hyperpermeable and compressed vessels (e.g., subset of mammary carcinomas), the two strategies need to be combined for improved treatment outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fibrinolytic therapy helps in dissolving fibrins in occluded vessels and improving the tumor vasculature [32,33,34,35,36].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [36]
Citations
Cites
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Gradishar, W. J., Tjulandin, S., Davidson, N. G. P., Shaw, H., Desai, N. P., Bhar, P., Hawkins, M., & O’Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,159
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,739
Cited by
Sorted by citations
Items 201–300 of 506
Nanogel-based nitric oxide-driven nanomotor for deep tissue penetration and enhanced tumor therapy
Wang, J., Liu, J., Sümbelli, Y., Shao, J., Shi, X., & van Hest, J. C. M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.021 · Cited by 30
Strategies to enhance the penetration of nanomedicine in solid tumors
Liu, S., Ren, Z., Yan, M., Ye, W., & Hu, Y. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123315 · Cited by 34
Vavourakis, V., Stylianopoulos, T., & Wijeratne, P. A. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006460 · Cited by 30
Multistep, effective drug distribution within solid tumors
Shemi, A., Khvalevsky, E. Z., Gabai, R. M., Domb, A. J., & Barenholz, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5051 · Cited by 30
Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities
Nezhadi, S., Saadat, E., Handali, S., & Dorkoosh, F. A. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1808000 · Cited by 28
Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
Muñoz, R., Girotti, A., Hileeto, D., & Arias, F. J. (2021) · Cancers · doi:10.3390/cancers13215414 · Cited by 31
Physical Forces in Glioblastoma Migration: A Systematic Review
Grossen, A. A., Smith, K., Coulibaly, N. J. O., Arbuckle, B., Evans, A., Wilhelm, S., Jones, K. L., Dunn, I. F., Towner, R. A., Wu, D. H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074055 · Cited by 29
Extension of a multiphase tumour growth model to study nanoparticle delivery to solid tumours
Wirthl, B., Kremheller, J., Schrefler, B. A., & Wall, W. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228443 · Cited by 29
The spatiotemporal journey of nanomedicines in solid tumors on their therapeutic efficacy
Qin, M., Xia, H., Xu, W., Chen, B., & Wang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115137 · Cited by 31
Transport and Lymphatic Uptake of Biotherapeutics Through Subcutaneous Injection
Han, D., Rahimi, E., Aramideh, S., & Ardekani, A. M. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.09.045 · Cited by 28
Souri, M., Elahi, S., & Soltani, M. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2323211 · Cited by 28
Chen, E., Zeng, Z., & Zhou, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189198 · Cited by 30
Andreou, T., Neophytou, C., Kalli, M., Mpekris, F., & Stylianopoulos, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1638186 · Cited by 27
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Urup, T. H., Michaelsen, S. R., Olsen, L. R., Toft, A. D., Christensen, I. J., Grunnet, K., Winther, O., Broholm, H., Kosteljanetz, M., Issazadeh‐Navikas, S., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.05.005 · Cited by 28
Photoacoustic imaging for the evaluation of early tumor response to antivascular treatment
Yang, J., Guang, Z., Li, Q., Liao, C., Huang, L., Ke, T., Jiang, H., & Dan, H. (2019) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2018.11.06 · Cited by 26
Guarino, B. D., Katari, V., Adapala, R. K., Bhavnani, N., Dougherty, J. A., Khan, M., Paruchuri, S. M., & Thodeti, C. K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.790489 · Cited by 27
Targeting cancer-associated fibroblasts with hydroxyethyl starch nanomedicine boosts cancer therapy
Wang, C., Wang, H., Yang, H., Chen, X., Wang, Q., Li, Z., Zhang, Z., Guan, J., Yu, X., Yang, X., et al. (2023) · Nano Research · doi:10.1007/s12274-023-5394-7 · Cited by 27
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
Lim, X. Y., Capinpin, S. M., Bolem, N., Foo, A. S. C., Yip, G. W., Kumar, A. P., & Teh, D. B. L. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10483 · Cited by 28
Physics of the tumor vasculature: Theory and experiment
Rieger, H., Fredrich, T., & Welter, M. (2016) · The European Physical Journal Plus · doi:10.1140/epjp/i2016-16031-9 · Cited by 26
Nieskoski, M. D., Marra, K. A., Gunn, J. R., Kanick, S. C., Doyley, M. M., Hasan, T. G., Pereira, S. P., Trembly, B. S., & Pogue, B. W. (2017) · Journal of Biomechanical Engineering · doi:10.1115/1.4036392 · Cited by 29
Mohammadi, M., & Chen, P. (2015) · Microvascular Research · doi:10.1016/j.mvr.2015.06.001 · Cited by 27
Möckel, D., Bartneck, M., Niemietz, P. M., Wagner, M., Ehling, J., Rama, E., Weiler, M., Gremse, F., Eulberg, D., Pola, R., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.044 · Cited by 26
Barbosa, L. C., Machado, G. C., Heringer, M., & Ferrer, V. P. (2024) · Neurogenetics · doi:10.1007/s10048-024-00763-x · Cited by 29
Bio responsive self-assembly of Au-miRNAs for targeted cancer theranostics
Cai, W., Feng, H., Yin, L., Wang, M., Jiang, X., Qin, Z., Liu, W., Li, C., Jiang, H., Weizmann, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102740 · Cited by 26
Sparse Optimal Control of a Phase Field Tumor Model with Mechanical Effects
Garcke, H., Lam, K. F., & Signori, A. (2021) · SIAM Journal on Control and Optimization · doi:10.1137/20m1372093 · Cited by 25
Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer
Zhang, H., Mi, J., Qi, X., Cao, W., Song, C., Zhang, N., & Yuan, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1256360 · Cited by 27
Zhang, B., Wang, H., Jiang, T., Jin, K., Luo, Z., Shi, W., Mei, H., Wang, H., Hu, Y., Pang, Z., et al. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1452243 · Cited by 26
The Effects of Physical Exercise on Tumor Vasculature: Systematic Review and Meta-analysis
Esteves, M., Monteiro, M. P., & Duarte, J. A. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1533-1876 · Cited by 26
Melanoma in the Eyes of Mechanobiology
Brás, M. M., Radmacher, M., Sousa, S. R., & Granja, P. L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00054 · Cited by 25
Goudar, V. S., Koduri, M. P., Ta, Y. N., Chen, Y., Chu, L., Lu, L., & Tseng, F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c18249 · Cited by 25
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
Singh, S., Saini, H., Sharma, A., Gupta, S., Huddar, V. G., & Tripathi, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1155254 · Cited by 25
Programing Assembling/Releasing Multifunctional miRNA Nanomedicine to Treat Prostate Cancer
Ma, D., Liu, H., Zhao, P., Li, Y., Zou, H., Zhao, X., Dai, H., Kong, X., & Liu, P. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b21707 · Cited by 25
Kashkooli, F. M., Bhandari, A., Gu, B., Kolios, M. C., Kohandel, M., & Zhan, W. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114138 · Cited by 28
Tehrani, M. H. H., Kashkooli, F. M., & Soltani, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108050 · Cited by 24
Datta, M., Via, L. E., Dartois, V. A., Weiner, D. M., Zimmerman, M., Kaya, F., Walker, A. M., Fleegle, J. D., Raplee, I., McNinch, C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321336121 · Cited by 23
Gao, H., Xue, J., Zhou, L., Lan, J., He, J., Na, F., Yang, L., Deng, L., & Lü, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.011 · Cited by 27
Cardiovascular fluid dynamics: a journey through our circulation
Menon, K., Hu, Z., & Marsden, A. L. (2024) · Flow · doi:10.1017/flo.2024.5 · Cited by 23
Conte, M., & Cauda, V. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200079 · Cited by 27
Shahvandi, M. K., Soltani, M., Kashkooli, F. M., Saboury, B., & Rahmim, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-18723-6 · Cited by 24
Translational nanomedicine potentiates immunotherapy in sarcoma by normalizing the microenvironment
Mpekris, F., Panagi, M., Michael, C., Voutouri, C., Tsuchiya, M., Wagatsuma, C., Kinoh, H., Osada, A., Akinaga, S., Yoshida, S., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.016 · Cited by 24
The emerging promise of tumour mechanobiology in cancer treatment
Papavassiliou, K. A., Basdra, E. K., & Papavassiliou, A. G. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.112938 · Cited by 23
Nanobubbles as ultrasound contrast agent for facilitating small cell lung cancer imaging
Wang, J., Zhou, X., Yan, J., Zheng, R., & Wang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.18155 · Cited by 22
Millet, M., Messaoud, R. B., Luthold, C., & Bordeleau, F. (2019) · Micromachines · doi:10.3390/mi10060418 · Cited by 24
Zhou, Z., Yang, Y., Zhang, Q., & Cheng, Y. (2020) · Biomaterials Science · doi:10.1039/c9bm01843c · Cited by 22
Fu, Y., Cen, D., Zhang, T., Jiang, S., Wang, Y., Cai, X., Li, X., & Han, G. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.126204 · Cited by 22
How Nanoparticles Interact with Cancer Cells
Syed, A. M., & Chan, W. C. W. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_10 · Cited by 23
Han, X., Liu, J., Zhang, Y., Tse, E., Yu, Q., Yu, L., Ma, Y., & Zheng, L. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.100984 · Cited by 21
Remodeling of extracellular matrix due to solid stress accumulation during tumor growth
Pirentis, A. P., Polydorou, C., Papageorgis, P., Voutouri, C., Mpekris, F., & Stylianopoulos, T. (2015) · Connective Tissue Research · doi:10.3109/03008207.2015.1047929 · Cited by 21
Stress alleviation strategy in cancer treatment: Insights from a mathematical model
Mpekris, F., Voutouri, C., Papageorgis, P., & Stylianopoulos, T. (2018) · ZAMM ‐ Journal of Applied Mathematics and Mechanics / Zeitschrift für Angewandte Mathematik und Mechanik · doi:10.1002/zamm.201700270 · Cited by 21
Scenario and future prospects of microRNAs in gastric cancer: A review.
Bhat, S. A., Majid, S., & Rehman, M. U. (2019) · PubMed Central · doi:10.22038/ijbms.2019.32399.7765 · Cited by 21
Estimation of Vascular Permeability in Irregularly Shaped Cancers Using Ultrasound Poroelastography
Islam, M. T., Tasciotti, E., & Righetti, R. (2019) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2019.2929134 · Cited by 21
MicroRNAs as therapeutic targets in breast cancer metastasis
Pouya, F. D., Rasmi, Y., Gazouli, M., Zografos, E., & Nemati, M. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00999-2 · Cited by 20
Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment
Melo, V. A., Bremer, E., & Martin, J. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.908389 · Cited by 20
Nikmaneshi, M. R., Jain, R. K., & Munn, L. L. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011131 · Cited by 22
The influence of anisotropic growth and geometry on the stress of solid tumors
Ramírez‐Torres, A., Rodrı́guez-Ramos, R., Merodio, J., Penta, R., Bravo‐Castillero, J., Guinovart-Dı́az, R., Sabina, F. J., García‐Reimbert, C., Sevostianov, I., & Conci, A. (2017) · International Journal of Engineering Science · doi:10.1016/j.ijengsci.2017.06.011 · Cited by 20
RETRACTED: Targeting Melanoma Hypoxia with the Food-Grade Lactic Acid Bacterium Lactococcus Lactis
Garza-Morales, R., Rendon, B. E., Malik, M. T., Garza-Cabrales, J. E., Aucouturier, A., Bermúdez‐Humarán, L. G., McMasters, K. M., McNally, L. R., & Gómez-Gutiérrez, J. G. (2020) · Cancers · doi:10.3390/cancers12020438 · Cited by 20
RetractedTargeting angiogenesis: Lessons from 25 years of normalizing tumor vasculature
Subudhi, S., Lee, S., & Jain, R. K. (2026) · Cell · doi:10.1016/j.cell.2026.03.016 · Cited by 29
Corr, S. J., Shamsudeen, S., Vergara, L. A., Ho, J. C.-S., Ware, M. J., Keshishian, V., Yokoi, K., Savage, D. J., Meraz, I. M., Kaluarachchi, W. D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136382 · Cited by 19
Intra-tumor distribution of PEGylated liposome upon repeated injection: No possession by prior dose
Nakamura, H., Lila, A. S. A., Nishio, M., Tanaka, M., Ando, H., Kiwada, H., & Ishida, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.002 · Cited by 19
Brain tumor vessels—a barrier for drug delivery
Hempel, C., Johnsen, K. B., Kostrikov, S., Hamerlik, P., & Andresen, T. L. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09877-8 · Cited by 18
Han, D., Li, C., Araimdeh, S., Sree, V. D., Rahimi, E., Tepole, A. B., & Ardekani, A. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.045 · Cited by 19
Harkos, C., Stylianopoulos, T., & Jain, R. K. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011740 · Cited by 19
Engineering nanoparticles to tackle tumor barriers
Li, J.-X., Huang, Q., Zhang, J., & Du, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00967a · Cited by 19
Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas
Kieler, M., Unseld, M., Bianconi, D., & Prager, G. W. (2018) · Pancreas · doi:10.1097/mpa.0000000000000970 · Cited by 18
Bioengineered Ionic Liquid for Catheter‐Directed Tissue Ablation, Drug Delivery, and Embolization
Keum, H., Albadawi, H., Zhang, Z., Graf, E. H., dos Santos, P. R., Gunduz, S. G., & Öklü, R. (2024) · Advanced Materials · doi:10.1002/adma.202309412 · Cited by 18
Chung, T. K., Warram, J. M., Day, K. E., Hartman, Y. E., & Rosenthal, E. L. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1016664 · Cited by 18
Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents
Lucas, A. T., Madden, A. J., & Zamboni, W. C. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1057496 · Cited by 18
Longobardi, G., Moore, T. L., Conte, C., Ungaro, F., Satchi‐Fainaro, R., & Quaglia, F. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1990 · Cited by 19
Strategies of targeting pathological stroma for enhanced antitumor therapies
Zhu, Y., Yu, F., Tan, Y., Yuan, H., & Hu, F. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104401 · Cited by 16
Choi, J. U., Lee, N. K., Seo, H., Chung, S. W., Al-Hilal, T. A., Park, S. J., Kweon, S., Min, N., Kim, S. K., Ahn, S.-H., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002332 · Cited by 17
Xiao, N., Liu, J., Liao, L., Sun, J., Jin, W., & Shu, X. (2018) · Ultrasound Quarterly · doi:10.1097/ruq.0000000000000381 · Cited by 18
The use of MR perfusion in assessing the efficacy of treatment for malignant brain tumors
Александровна, Р. В., Sergeev, N. I., Padalko, V. V., Kotlyarov, P. M., & Solodkiy, V. А. (2019) · Burdenko s Journal of Neurosurgery · doi:10.17116/neiro201983041113 · Cited by 16
Martin, J. D., Lanning, R. M., Chauhan, V. P., Martin, M. R., Mousa, A. S., Kamoun, W. S., Han, H., Lee, H., Stylianopoulos, T., Bawendi, M. G., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0486 · Cited by 16
Akalın, A. A., Dedekargınoğlu, B., Choi, S. R., Han, B., & Özçelikkale, A. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03298-8 · Cited by 16
Zhang, Y., Zhang, J., Luo, T., Cai, Z., Yang, G., Li, H., Wei, J., Zhu, Q. N., Li, P., Dong, X., et al. (2023) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2023.106619 · Cited by 16
Dose-Specific Intratumoral GM-CSF Modulates Breast Tumor Oxygenation and Antitumor Immunity
Mihalik, N. E., Steinberger, K. J., Stevens, A. M., Bobko, A. A., Hoblitzell, E. H., Tseytlin, O., Akhter, H., Dziadowicz, S. A., Wang, L., O’Connell, R. C., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300326 · Cited by 18
Madden, A. J., Oberhardt, B. J., Lockney, D. M., Santos, C., Vennam, P., Arney, D., Franzen, S., Lommel, S. A., Miller, C. R., Gehrig, P. A., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0421 · Cited by 16
Moody, A. S., Dayton, P. A., & Zamboni, W. C. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2020.94 · Cited by 18
Chen, H., Tu, W., Lu, Y., Zhang, Y., Xu, Y., Chen, X., Zhu, M., & Liu, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113114 · Cited by 16
Finite Element Modeling of Avascular Tumor Growth Using a Stress-Driven Model
Iranmanesh, F., & Nazari, M. A. (2017) · Journal of Biomechanical Engineering · doi:10.1115/1.4037038 · Cited by 16
Lotfi, R., Steppe, L., Hang, R., Rojewski, M., Massold, M., Jahrsdörfer, B., & Schrezenmeier, H. (2018) · Immunity Inflammation and Disease · doi:10.1002/iid3.236 · Cited by 16
Yin, C., Wang, S., Ren, Q., Shen, X., Chen, X., Liu, Y., & Liu, S. (2019) · 中国科学通报:英文版 · doi:10.1016/j.scib.2019.04.017 · Cited by 16
Classic versus innovative strategies for immuno-therapy in pancreatic cancer
Formelli, M. G., Palloni, A., Tavolari, S., Deiana, C., Andrini, E., Marco, M. D., Campana, D., Lamberti, G., & Brandi, G. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115671 · Cited by 16
Physiologically based pharmacokinetic model for CAR-T cell delivery and efficacy in solid tumors
Hadjigeorgiou, A. G., Munn, L. L., Stylianopoulos, T., & Jain, R. K. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2522634122 · Cited by 15
Rapaport, E., Salikhova, A. Y., & Abraham, E. H. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9450-y · Cited by 15
Yunna, C., Hu, M., Fengling, W., Wang, L., & Weidong, C. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.05.007 · Cited by 15
Wu, Y.-G., Zheng, Y., Shen, Z., Ge, W., Xie, Y.-S., & Li, C. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1526 · Cited by 15
Durymanov, M. O., Yarutkin, A. V., Bagrov, D. V., Klinov, D. V., Kedrov, A. V., Chemeris, N. K., Rosenkranz, A. A., & Sobolev, A. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.011 · Cited by 15
Shia, W.-C., Chen, D., Huang, Y.-L., Wu, H., & Kuo, S. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/19/7763 · Cited by 15
Impact of metronomic neoadjuvant chemotherapy on early tongue cancer
Kina, S., Nakasone, T., Kinjo, T., Maruyama, T., Kawano, T., & Arasaki, A. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3141-4 · Cited by 15
Assessing the benefits of drug delivery by nanocarriers: a partico/pharmacokinetic framework
Siegel, R. A., Kirtane, A. R., & Panyam, J. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2632733 · Cited by 14
Hadjigeorgiou, A. G., & Stylianopoulos, T. (2024) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-024-00002-2 · Cited by 15
Kim, C., Kim, H. S., Shim, W. H., Choi, C. G., Kim, S. J., & Kim, J. H. (2016) · Radiology · doi:10.1148/radiol.2016152152 · Cited by 14
Himri, I., & Guaâdaoui, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813665-2.00001-6 · Cited by 14
Melanoma tumour vasculature heterogeneity: from mice models to human
Pautu, V., Mellinger, A., Resnier, P., Lepeltier, É., Martin, L., Boussemart, L., Letournel, F., Passirani, C., & Clere, N. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2809-z · Cited by 15
Johansen, M. D., Urup, T. H., Holst, C. B., Christensen, I. J., Grunnet, K., Lassen, U., Friis, S., & Poulsen, H. S. (2018) · Cancer Investigation · doi:10.1080/07357907.2018.1544639 · Cited by 14
Asgari, H., Soltani, M., & Sefidgar, M. (2018) · Microvascular Research · doi:10.1016/j.mvr.2018.02.002 · Cited by 14
Ha, H.-J., Choi, Y., Kim, N.-H., Kim, J., Jang, J., Niepa, T. H. R., Tanaka, M., Lee, H.-Y., & Choi, J. H. (2025) · Biomaterials Research · doi:10.34133/bmr.0144 · Cited by 13
Responsive nanomedicine strategies achieve pancreatic cancer precise theranostics
Li, F., Tang, Z., Zheng, Y., Jiang, T., Deng, L., Dai, W., Zhao, Y., Zheng, N., Liu, S., Fan, Y., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.08.012 · Cited by 18
Liu, A. J., Gammon, S. T., Pisaneschi, F., Boda, A. R., Ager, C. R., Piwnica-Worms, D. R., Hong, D. S., & Curran, M. A. (2023) · JCI Insight · doi:10.1172/jci.insight.169150 · Cited by 15
Metadata
- Authors
- Stylianopoulos, T., & Jain, R. K.
- Affiliations
- University of Cyprus (CY)
- Harvard University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-10-28
- Volume
- 110
- Issue
- 46
- Pages
- 18632-18637
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3832007
- OpenAlex
- W1964128680
- Cited by
- 508
- References
- 67
- Citations by year
- 2026: 49 · 2025: 46 · 2024: 45 · 2023: 47 · 2022: 29 · 2021: 35 · 2020: 53 · 2019: 29 · 2018: 39 · 2017: 35 · 2016: 34 · 2015: 47 · 2014: 19 · 2013: 1
- FWCI
- 34.83
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- other-oa
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA115767, T32CA073479, R01CA085140, R01CA096915, P01CA080124, R01CA126642, R01CA098706)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor perfusion, drug delivery, solid tumors, vascular normalization, solid stress, tumor hypoxia, vascular permeability, interstitial fluid flow, mathematical model, drug distribution, glioblastoma, pancreatic ductal adenocarcinoma, breast cancer
- MeSH terms
- Biomechanical Phenomena, Capillary Permeability, Computer Simulation, Humans, Models, Biological, Neoplasms, Regional Blood Flow, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review